Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Perpetua Medical

5.26 SEK

+0.38 %

Less than 1K followers

PERP B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+0.38 %
+17.15 %
+5.41 %
+18.20 %
+22.90 %
+3.14 %
-90.09 %
-94.57 %
-97.41 %

Perpetua Medical is a serial acquirer of profitable companies in the healthcare sector. The company's operations are conducted according to a decentralized ownership model, where operations and decision-making take place in independent subsidiaries. The name Perpetua (Latin for 'eternal') reflects the strategy of acquiring and long-term ownership of companies without any fixed time horizon. Until 2023, the company had a different business focus and was called Pharmacolog. The head office is in Uppsala.

Read more
Market cap
23.78M SEK
Turnover
605.5 SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
19.12.
2025

Extraordinary general meeting '25

20.2.
2026

Annual report '25

All
Press releases
ShowingAll content types
Regulatory press release6/18/2024, 8:15 PM

Perpetua Medical AB: Perpetua Medical has entered a letter of intent regarding the acquisition of a majority stake in ES-Medical AB

Perpetua Medical
Regulatory press release6/14/2024, 11:15 AM

Perpetua Medical AB: Resolutions from the Annual General Meeting 2024 in Pepetua Medcial

Perpetua Medical
Regulatory press release6/12/2024, 6:30 AM

Perpetua Medical AB: Perpetua Medical is offered a loan facility of up to SEK 25 million

Perpetua Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release5/17/2024, 6:30 AM

Perpetua Medical AB: Perpetua Medical publishes interim report January - March 2024

Perpetua Medical
Regulatory press release5/15/2024, 7:30 AM

Perpetua Medical AB: NOTICE OF ANNUAL GENERAL MEETING IN PERPETUA MEDICAL AB (PUBL)

Perpetua Medical
Regulatory press release4/24/2024, 6:30 AM

Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFO

Perpetua Medical
Press release4/23/2024, 6:30 AM

Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name

Perpetua Medical
Regulatory press release4/17/2024, 6:30 AM

Nolsterby Invest AB has increased its holding further in Pharmacolog

Perpetua Medical
Regulatory press release4/16/2024, 2:42 PM

Pharmacolog: ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 2024

Perpetua Medical
Regulatory press release4/16/2024, 1:07 PM

Pharmacolog publishes annual report for 2023

Perpetua Medical
Regulatory press release4/8/2024, 6:30 AM

Nolsterby Invest AB has increased its holding in Pharmacolog

Perpetua Medical
Regulatory press release4/4/2024, 6:30 AM

Pharmacolog announces the appointment of Anders Hedlund as interim CEO

Perpetua Medical
Regulatory press release3/14/2024, 9:20 AM

Pharmacolog: NOTICE TO EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL)

Perpetua Medical
Regulatory press release3/14/2024, 9:15 AM

Pharmacolog provides update on new business direction and proposes name change

Perpetua Medical
Regulatory press release3/1/2024, 11:55 AM

Pharmacolog announces upcoming change in management

Perpetua Medical
Regulatory press release2/27/2024, 10:38 AM

Warrants of series TO3 were subscribed to approximately 90.4 percent and Pharmacolog receives approximately SEK 2.3 million

Perpetua Medical
Regulatory press release2/20/2024, 1:10 PM

Major shareholder in Pharmacolog exercises warrants of series TO3 for at least approximately SEK 0.54 million

Perpetua Medical
Regulatory press release2/20/2024, 7:30 AM

The last day of trading with warrants of series TO3 in Pharmacolog is today, February 20, 2024

Perpetua Medical
Regulatory press release2/16/2024, 7:30 AM

Year-end bulletin Pharmacolog 2023

Perpetua Medical
Regulatory press release2/15/2024, 7:30 AM

Pharmacolog investigates the possibilities for a new business direction

Perpetua Medical
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.